John French
Liverpool Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name John French as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:09 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03618108 · Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart DiseaseCadrock Pty. Ltd. · terminated · Coronary Heart Disease, Chlamydophila Pneumoniae Infections · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 12 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:09 UTC. The ranking covers the 200 most relevant of 197 PubMed records, and a shared surname and initials can bring in a namesake. All 197 on PubMed
- A comparison of albumin and saline for fluid resuscitation in the intensive care unit.N Engl J Med · 20041,691 citationsRCR 51.4
- Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy.Epilepsia · 20101,415 citationsRCR 47.9
- 653 citationsRCR 36.8
- Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy.Neurology · 2015619 citationsRCR 27.2
- 563 citationsRCR 21.0
- Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.Neurology · 2012401 citationsRCR 14.7
- Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.Neurology · 2012367 citationsRCR 13.5
- Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.Epilepsia · 2013350 citationsRCR 14.2
- Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.Eur Heart J · 2011318 citationsRCR 9.1
- 309 citationsRCR 8.7